INTEGRILIN® (eptifibatide) Injection Clinical Support Slide Lecture ...

MI Ratepursuit6%4%Early Use of EptifibatidePre-PCI* in ACS67.2% (P = 0.001)Aspirin + heparin5.5%(n = 631)2%Aspirin + heparin + eptifibatide 180/2 †1.8%(n = 619)01 2 3Days from EnrollmentPost-randomization analysis in a subset of patients prior to undergoing early PCI; all patients were to receive aspirinand heparin therapy.*PCI = percutaneous coronary intervention; † 180/2 = 180-mcg/kg bolus followed by a 2-mcg/kg/min infusion.Fintel DJ, et al. Clin Cardiol. 2000;23(Suppl V):V1-V12; Data on file, Millennium Pharmaceuticals, Inc.